The German drugmaker will pay the NIH $791.5 million, while the University of Pennsylvania will get up to $467 million ...
Penn has reached an agreement to resolve a dispute over Covid-19 royalties the Philadelphia university alleged it was owed.
The new $467 million includes $400 million in royalties for the Pfizer-BioNTech vaccine from 2020 through 2023.
The University of Pennsylvania expects to receive $467 million from a German COVID-19 vaccine manufacturer after the pair ...
Morgan Stanley analyst Terence Flynn notes that BioNTech (BNTX) announced last week that it had reached a settlement agreement with the National Institutes of Health and University of Pennsylvania ...
University of Pennsylvania will receive $467 million from BioNTech as part of a settlement in a lawsuit over COVID-19 vaccine ...
So, the US’ National Institutes of Health (NIH) in March this year and the University of Pennsylvania in August had filed suits against BioNTech for underpaying the royalties due to them on the sale ...
Moderna and BioNTech, two rising stars in biotech ... on the mRNA technology developed by Katalin Kariko from the University of Pennsylvania and her collaborator Drew Weissman, an immunologist ...